...
首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Formulation and Optimization of Omeprezole Floating Tablet by Wet Granulation Technique
【24h】

Formulation and Optimization of Omeprezole Floating Tablet by Wet Granulation Technique

机译:湿法制粒制备奥美拉唑漂浮片的工艺优化

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Omaprezole is a proton pump inhibitor, antacid drug. It is categorized as class II in BCS system of classification of drugs. Omaprazole inhibits the H(+)-K(-) ATPase in the proton pump of gastric parietal cells and highly effective inhibitor of gastric acid secretion. Floating tablet is nowadays considered as one of the best method to enhance the retention time of tablet in stomach. To get a better dissolution rate, the retention time of Omaprazole is enhanced by the floating technique. The aim of the work is to formulate the floating tablet of Omaprazole and evaluation of tablets invitro performance. The floating tablets are prepared by using two different polymers; HPMC K15, HPMC K100. Wet granulation method was used to prepare tablet. The polymers added in different ratios. The increasing concentration of polymers is responsible for enhancement of drug content and percent yield due to increase in the swallability of polymer.Invitro drug release study was performed using United State Pharmacopoeia (USP) type II dissolution test apparatus employing paddle stirrer at 50 rpm using 900ml of 0.1 N HCL buffer maintained at 37?C±0.5?C as the dissolution medium. The FTIR, DSC studies of Omaprazole floating tablet indicated the phase inversion of Omaprazole from crystalline to amorphous form. The F3 formulation show increased drug release as compare to pure drug in 24 hrs. It can be concluded that the floating tablet of Omaprazole prepared with mixture of HPMC K15 and HPMC K100 has greater retention time than pure drug and marketed formulation.
机译:奥马普唑是质子泵抑制剂,抗酸药。在BCS药品分类系统中,它被分类为II类。 Omaprazole抑制胃壁细胞质子泵中的H(+)-K(-)ATPase和高效的胃酸分泌抑制剂。如今,漂浮片剂被认为是延长片剂在胃中保留时间的最佳方法之一。为了获得更好的溶解速率,通过浮动技术可以延长奥马拉唑的保留时间。该工作的目的是配制奥帕唑的漂浮片剂并评估其体外性能。漂浮片剂是通过使用两种不同的聚合物制备的。 HPMC K15,HPMC K100。采用湿法制粒的方法制备片剂。聚合物以不同比例添加。聚合物浓度的增加归因于聚合物可持壁性的提高,从而导致药物含量和产率的提高。使用美国药典(USP)II型溶出度测试设备进行体外药物释放研究,该设备使用桨式搅拌器,转速为50 rpm,使用900 ml保持在37℃±0.5℃的0.1N HCL缓冲液作为溶解介质。 FTIR,DSC对Omaprazole漂浮片的研究表明Omaprazole从结晶形式转变为无定形形式。与纯药物相比,F3制剂在24小时内显示出更高的药物释放。可以得出结论,用HPMC K15和HPMC K100的混合物制备的奥马拉唑漂浮片剂的保留时间要比纯药物和市售制剂更长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号